Health News

(MedPage Today) — The emergency contraceptive drug ulipristal acetate (ella) can be marketed in the U.S. for preventing pregnancy up to five days after unprotected sex, the FDA said.

Read more

Filed under: Pharmacy News
Tags: Drug, Pharmacy, Pregnancy, Sex

Related posts

• Advisory panel recommends FDA approve new "morning after" pill (0)
  The New York Times: A Food and Drug Administration advisory panel Thursday recommended that the agency approve "a medicine that could help prevent pregnancy if taken as late as five days after unprotected sex. The pill, called ella, sprang from government labs and appears to be more effective than Plan B, a morning-after pill now [...]
  
  
• Viewpoints: Shredding Bachmann’s vaccine argument; ’super’ or ’stupor’ committee; Bennet on outmoded drug safety rules (0)
  Vaccines were the biggest losers in Monday's GOP presidential candidate's debate, specifically those that are intended to prevent cervical cancer. The main route of HPV infection is sex. That's why you need to vaccinate girls before they become sexually active. The vaccines are exceedingly safe, studies show. There have been very few reports of serious [...]
  
  
• Valproate exposure during pregnancy can impair a child’s cognitive development (0)
  Three-year-olds whose mothers took the antiepileptic drug valproate during pregnancy had average IQs six to nine points lower than children exposed to three other antiepileptic drugs, a landmark multi-center study has found. Read more [tags] Pharmacy News [/tags]
  
  
• Use of nonaspirin NSAIDs during early pregnancy raises risk of miscarriage in women (0)
  The risk of miscarriage is 2.4 times greater for women who took any type and dosage of nonaspirin nonsteroidal anti-inflammatory drugs (NSAIDs) in early pregnancy, according to a University of Montreal study in CMAJ. Read more [tags] Pharmacy News [/tags]
  
  
• Topamax medication during pregnancy can lead to increased risk of oral birth defects in babies (0)
  New data suggest that the drug Topamax and its generic versions increase the risk for the birth defects cleft lip and cleft palate in babies born to women who use the medication during pregnancy, the U.S. Food and Drug Administration said today. Read more [tags] Pharmacy News [/tags]